Thermon Form 4: Director Angela Strzelecki Adds 1,008 Shares

Rhea-AI Filing Summary

Thermon Group Holdings director Angela Strzelecki received 1,008 shares of Thermon common stock on 10/01/2025 at a reported price of $27.28 per share under the issuer's Non-Employee Director Compensation Program. After the award, Strzelecki beneficially owns 12,372 shares in a direct ownership form. The Form 4 was signed on 10/02/2025 by Ryan Tarkington as attorney-in-fact. The filing identifies Strzelecki as a director and confirms this transaction was reported as an acquisition of non-derivative securities.

Positive

• 1,008 shares awarded to a director under the Non-Employee Director Compensation Program, increasing insider alignment with shareholders
• Post-transaction direct ownership of 12,372 shares clearly disclosed

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine director equity award; small incremental insider ownership.

The disclosure documents a standard non-employee director equity award of 1,008 shares at $27.28 under the company's director compensation program. This increases the director's direct stake to 12,372 shares. The transaction is non-derivative and does not indicate sales, option exercises, or changes to outstanding convertible instruments. For investors, the filing is informational and routine rather than materially transformative.

Corporate Governance Expert

TL;DR: Typical compensation disclosure consistent with governance practices.

The Form 4 shows compliance with Section 16 reporting for an equity grant to a director. It specifies the grant source as the Non-Employee Director Compensation Program and records direct beneficial ownership post-award. The filing is complete with an attorney-in-fact signature, meeting procedural requirements for insider reporting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Strzelecki Angela

(Last) (First) (Middle)

7171 SOUTHWEST PARKWAY

BUILDING 300, SUITE 200

(Street)

AUSTIN TX 78735

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Thermon Group Holdings, Inc. [ THR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		1,008(1)	A	$27.28	12,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award pursuant to Issuer's Non-Employee Director Compensation Program.

Remarks:

	/s/ Ryan Tarkington, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Angela Strzelecki report on the Form 4 for Thermon (THR)?

She reported an acquisition of 1,008 shares of Thermon common stock on 10/01/2025 at a reported price of $27.28 per share.

How many Thermon (THR) shares does Angela Strzelecki beneficially own after the reported transaction?

The Form 4 shows 12,372 shares beneficially owned following the reported acquisition.

Under what program were the Thermon (THR) shares awarded to the director?

The shares were awarded pursuant to the issuer's Non-Employee Director Compensation Program.

When was the Form 4 for this Thermon (THR) transaction signed and by whom?

The filing includes a signature by Ryan Tarkington, Attorney-in-Fact dated 10/02/2025.

Does the Form 4 report any derivative transactions or dispositions for Thermon (THR)?

No. The filing discloses a non-derivative acquisition only and does not report derivative transactions or dispositions.